Prevent preclinical drug development program: preclinical efficacy and intermediate biomarkers (POP: 1/25/2019-1/24/2024).
Ended Awarded Last action
- Contract number
- 75N91019D00012
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $2,270,972 obligated
Award facts
- Opportunity
- Combined order value
- $2,270,972 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 3% used
- $74,995,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $74,995,000 multiple-award contract, titled the "PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers," supports preclinical efficacy and biomarker evaluation, manufacturing, and toxicology/pharmacology testing for new cancer prevention and treatment therapies. IITRI, a division of the Illinois Institute of Technology, has extensive experience providing these preclinical drug development services to federal agencies through various IDIQ contracts. The contract has no set-aside designation.
Under this IDIQ, IITRI has been awarded several delivery orders to date. These include a $532,562 firm fixed price task order to evaluate a breast cancer prevention agent, a $3,033,668 firm fixed price task order for preclinical development of an RNA vaccine for prostate cancer immunoprevention, and a $2,398 cost-plus-fixed-fee task order for a contract orientation and kickoff meeting. The contracted work is primarily performed at IITRI's facilities in Chicago, Illinois. These task orders demonstrate the breadth of preclinical research activities supported by the overall PREVENT program, which aims to accelerate the development of promising cancer prevention and treatment agents.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91019D00012?
75N91019D00012 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on January 23, 2019.
How much is contract 75N91019D00012 worth?
Orders under 75N91019D00012 have obligated $2,270,972. 75N91019D00012's own ceiling is $74,995,000.
How many orders have been placed under contract 75N91019D00012?
3 orders have been placed under 75N91019D00012, the latest on September 6, 2021.
Who can order from contract 75N91019D00012?
75N91019D00012 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91019D00012 part of a contract vehicle?
Yes. 75N91019D00012 is part of PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91019D00012 competed?
The extent of competition for 75N91019D00012 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV